To unlock this feature and to subscribe to our weekly evidence emails, please create a FREE orthoEvidence account.

SIGNUP

Already Have an Account?

Loading...
Visit our Evidence-Based Covid-19 Website and Stay Up to Date with the latest Research.
Ace Report Cover

Similar blood loss, Hb drop, and transfusion rate between oral and IV TXA in minimally invasive THA

Download
Share
Reprints
Cite This
About
+ Favorites
Share
Reprints
Cite This
About
+ Favorites
Ace Report Cover
December 2018

Similar blood loss, Hb drop, and transfusion rate between oral and IV TXA in minimally invasive THA

Vol: 7| Issue: 12| Number:20| ISSN#: 2564-2537
Study Type:Randomized Trial
OE Level Evidence:1
Journal Level of Evidence:N/A

Efficacy of oral tranexamic acid on blood loss in primary total hip arthroplasty using a direct anterior approach: a prospective randomized controlled trial

Int Orthop. 2018 Nov;42(11):2535-2542. doi: 10.1007/s00264-018-3846-6

Contributing Authors:
FX Pei PD Kang Y Xia X Shi H Zhao M Xiang

Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here

Synopsis

120 patients scheduled for total hip arthroplasty through a direct anterior approach were randomized to one of three groups: oral tranexamic acid administration, intravenous tranexamic acid administration, or control. The purpose of this study was to compare blood loss parameters, transfusion measures, and incidence of complications between the three groups. Results demonstrated significant differ...

CME Image

Did you know that you’re eligible to earn 0.5 CME credits for reading this report!

LEARN MORE

Join the Conversation

Please Login or Join to leave comments.

Learn about our AI Driven
High Impact Search Feature

High Impact Icon

Our AI driven High Impact metric calculates the impact an article will have by considering both the publishing journal and the content of the article itself. Built using the latest advances in natural language processing, OE High Impact predicts an article’s future number of citations better than impact factor alone.

Continue